Cisplatin sensitivity is related to late DNA damage processing and checkpoint control rather than to the early DNA damage response
Authors:
- Anamaria BrozovicAnamaria Brozovic
- Julia DamrotJDJulia Damrot
- Roman TsarykRTRoman Tsaryk
- Lars HelbigLHLars Helbig
- Teodora NikolovaTNTeodora Nikolova
- Cornelia HartigCHCornelia Hartig
- Maja OsmakMOMaja Osmak
- Wynand Paul RoosWRWynand Paul Roos
- Bernd KainaBKBernd Kaina
- Gerhard FritzGFGerhard Fritz
- 1 November 2009
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 670 (1-2) , 32-41
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (DGF Fr-1241/5-3)
- Ministarstvo Obrazovanja, Znanosti i Sporta (098-0982913-2748)
This publication has 60 references indexed in Scilit:
- Kinetics of H2AX phosphorylation after exposure to cisplatinCytometry Part B: Clinical Cytometry, 2008
- Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancerInternational Journal of Cancer, 2008
- The γ‐H2A.X: Is it just a surrogate marker of double‐strand breaks or much more?Environmental and Molecular Mutagenesis, 2007
- Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistanceCancer Letters, 2007
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamideCancer Letters, 2006
- Prediction of treatment outcome by cisplatin‐DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin‐radiation (RADPLAT)International Journal of Cancer, 2006
- XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cellsDNA Repair, 2006
- Long‐term activation of SAPK/JNK, p38 kinase and fas‐L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistanceInternational Journal of Cancer, 2004
- Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell linesInternational Journal of Cancer, 2004